Shapiro+Raj
Shapiro+Raj is a Chicago-based life sciences strategic insights consultancy serving top global biopharmaceutical companies with proprietary research methodologies and its AI agent Stella.ai.
- Company typePrivate
- Founded1961
- HeadquartersChicago, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Shapiro+Raj does
Shapiro+Raj is a US-based, privately held strategic insights consultancy focused on the global life sciences industry. Founded in 1961 as Leo J. Shapiro & Associates, LLC and headquartered in Chicago, the firm serves pharmaceutical, biotechnology, and medical-device clients across the commercialization lifecycle — from early pipeline and innovation work through market-shaping strategy, TPP testing, segmentation, positioning, communication testing, and launch execution. It claims partnerships with 8 of the top 10 global biopharmaceutical companies and delivers projects across 12 or more markets including the US, Germany, France, UK, Spain, Japan, and China.
The firm's core technology stack centers on Stella.ai, a proprietary AI agent launched commercially in April 2026 and built specifically for life sciences insights teams. Stella synthesizes primary research, generates digital avatars trained on real respondent data, and supports predictive scenario modeling (e.g., TPP simulator, adoption-curve forecasting via PROsician™). It is wrapped by the TechManity™ methodology, which integrates human social-science expertise, AI, and curated tech (including the MIT-licensed Luminoso engine inside S+R AQuA™) into proprietary frameworks such as WithInsight™ (dual-process System 1/System 2 capture), Fishbowl, and Guided Deliberations™. The firm reports operational outcomes including 25–40% faster path-to-market versus legacy approaches, 6–9+ months saved on lifecycles, and a claimed 87% predictive accuracy across engagements.
Shapiro+Raj operates a hybrid revenue model: traditional project-based strategic consulting engagements remain the core revenue stream, while Stella.ai introduces a platform access layer (potentially subscription or usage-based) targeting mid-size and emerging pharma that require enterprise-grade intelligence without enterprise-scale research budgets. Go-to-market is enterprise sales-led through direct engagement, thought leadership (Perspectives blog, case studies), and industry events, with leadership additions (President Amir Kapadia, CPO Scott Swigart) explicitly tasked with scaling the AI product. The firm is founder/management-controlled under Chairman and CEO Zain Raj, with no disclosed external institutional investment.
Shapiro+Raj firmographics
Firmographics- Name
- Shapiro+Raj
- Legal name
- Leo J. Shapiro & Associates, LLC.
- Website
- https://shapiroraj.com
- Company type
- Private
- Founded year
- 1961
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Shapiro+Raj is a Chicago-based life sciences strategic insights consultancy serving top global biopharmaceutical companies with proprietary research methodologies and its AI agent Stella.ai.
- Ownership category
- akta.pro rank
Shapiro+Raj industry classification
Industry- Product category
- Pharmaceutical Market Research Consulting
- NAICS
- Marketing Research and Public Opinion Polling (541910), Software Publishers (51321), Professional, Scientific, and Technical Services (541)
- SIC
- Services-Management Consulting Services (8742), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Competitive Intelligence & Benchmarking (BPAHALAB)
- akta.pro secondary industries
- Pricing, Revenue & Commercial Analytics (BPAHALAM), Industry/Domain Analytics Solutions & Accelerators (BPAEAHAK), Data, Analytics & AI Consulting (BPAHAEAF)
Keywords
Where Shapiro+Raj is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Shapiro+Raj business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Strategic Insights Consulting Services: Core revenue from strategic insights consulting for life sciences companies across the pharmaceutical lifecycle. Services include market research, brand strategy, positioning, message testing, patient journey research, TPP testing, and launch execution support. Project-based engagements with pharmaceutical, biotech, and medical device companies.
- Stella.ai Platform Access: Commercial availability of proprietary AI Agent for life sciences marketing and insights. Revenue potentially from platform subscriptions or usage-based access for enterprise teams.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Shapiro+Raj product offering
Product offeringCore offering
Shapiro+Raj is a life sciences strategic insights consultancy that helps pharmaceutical, biotech, and medical device companies accelerate commercialization through market research, brand positioning, message testing, patient journey mapping, segmentation, TPP testing, and launch strategy. The firm blends behavioral science expertise with its proprietary AI agent Stella.ai and proprietary methodologies (TechManity, PROsician, WithInsight, Fishbowl, Guided Deliberations, S+R AQuA, IdealSpaces) to deliver insights 25-40% faster than legacy approaches.
Product overview
Shapiro+Raj is a life sciences strategic insights consultancy operating as a platform-plus-services model centered on its proprietary AI agent Stella.ai. The core offering combines the TechManity™ methodology framework—which integrates human social science expertise with AI intelligence and continuous data—with specialized research products including Stella.ai (the AI agent platform), Digital Avatars (AI-powered persona simulations), and various proprietary research methodologies (PROsician™, WithInsight™, Guided Deliberations™, Fishbowl, S+R AQuA™). Services span the pharmaceutical lifecycle from early pipeline innovation through market growth, including TPP testing, patient segmentation, brand positioning, message testing, and launch strategy. The company targets pharmaceutical, biotech, and medical device brands seeking accelerated commercialization.
Differentiator
Problem solved
Functional benefit
Brands
- Stella.ai: Proprietary AI Agent platform built specifically for the life sciences industry, enabling insights teams to connect and interrogate data across their entire ecosystem on demand.
- TechManity™
- PROsician™
- Fishbowl
- S+R AQuA™
- WithInsight™
- IdealSpaces™
Products and services
- Stella.ai Proprietary AI agent built specifically for the life sciences industry that enables insights teams to connect and interrogate data across their entire ecosystem on demand, synthesizing primary research, simulating behaviors via digital avatars, and predicting outcomes with anti-hallucination design. Sold as a platform offering to life sciences marketing and insights teams.
- Strategic Insights Consulting Services End-to-end strategic insights engagements across the pharmaceutical lifecycle covering early pipeline innovation, market shaping strategy, communication and growth, brand positioning, message testing, patient journey research, TPP testing, segmentation, launch strategy, and tracking/ATU studies for top pharmaceutical, biotech, and medical device companies.
- S+R Future-Casting Roundtables Facilitated roundtable sessions bringing together diverse stakeholder perspectives to pressure-test hypotheses, co-create future scenarios, and shape strategic planning for pharmaceutical launches.
Quantifiable outcome
- Lifecycles accelerated 40% faster than legacy approaches
- +7 more outcomes
Companies that use Shapiro+Raj
Customer profileNamed customers14 records
Segments4 records
Ideal customer profiles3 records
Shapiro+Raj technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability7 records
Feature9 records
Shapiro+Raj partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Luminoso (MIT)supportingLicensed AI-enabled text analytic engine from MIT. Used within S+R AQuA™ (Advanced Qualitative Analytics) platform to generate full picture of overt and latent connections in research data with depth and speed. The partnership provides access to MIT-developed natural language understanding technology.
Scale indicators9 records
Recent moves6 records
Expansion highlights6 records
Shapiro+Raj competitors and assessment
Company assessmentBroad incumbents
- IQVIA: IQVIA is the largest life sciences data, analytics, and commercial insights provider globally. It competes with Shapiro+Raj on strategic insights for top pharma but operates as a broad incumbent across clinical, real-world evidence, and commercial engagements rather than specializing in AI-first pharma insights.
- Kantar Health (now part of Cerner/envision): Kantar is a broad market research and consumer insights provider with a dedicated life sciences practice. It competes with Shapiro+Raj on global brand tracking, patient research, and pharma market assessment at a much larger scale.
- DRG (Decision Resources Group) / Clarivate: DRG, now part of Clarivate, provides life sciences market intelligence, disease insights, and forecasting to pharma. It competes with Shapiro+Raj on therapy-area market assessment and competitive intelligence at a larger, more syndicated scale.
- Evidera (PPD / Thermo Fisher): Evidera provides health economics, outcomes research, and real-world evidence to biopharma. Adjacent to Shapiro+Raj's commercial insights practice, overlapping on evidence-based decision support for pharma launches.
Direct peers
- ZS Associates: ZS Associates is a leading management consulting firm with deep pharma commercial focus, providing strategy, sales, and marketing insights to top-10 pharma. It directly competes with Shapiro+Raj on commercial insights engagements and serves similar enterprise pharma clients.
- Trinity Life Sciences: Trinity Life Sciences is a life sciences strategic insights and analytics firm that competes directly with Shapiro+Raj across TPP testing, patient journey research, brand positioning, and launch strategy for top global pharma.
- Prescient Healthcare Group: Prescient Healthcare Group is a pharma strategy consultancy offering commercial insights, competitive intelligence, and brand strategy services. It overlaps with Shapiro+Raj on therapy-area insights, positioning, and market access advisory for mid-size and top-tier pharma.
- Syneos Health Consulting: Syneos Health Consulting provides commercial strategy and insights services to biopharma, including brand strategy, market shaping, and launch readiness. Direct overlap with Shapiro+Raj on commercial insights for pharma brands.
- Market Research.com / Lumanity: Lumanity (formerly SHG / Strategic Healthcare Group and Cello Health) provides life sciences consulting and insights. Direct overlap with Shapiro+Raj on commercial strategy, brand positioning, and HCP/patient insights engagements.
Emerging players
- Genesis Research: Genesis Research is a life sciences evidence and insights consultancy offering strategic insights, real-world evidence, and market access support to pharma. It is a smaller, emerging peer with comparable service lines to Shapiro+Raj's consulting side.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Shapiro+Raj social profiles
Digital presenceShapiro+Raj financial estimates
Financial estimateRevenue estimate
Valuation estimate
Shapiro+Raj leadership team
Management profileNumber of profiles
Profiles1 record
Shapiro+Raj funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Shapiro+Raj M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Shapiro+Raj
What does Shapiro+Raj do?
Shapiro+Raj is a life sciences strategic insights consultancy that helps pharmaceutical, biotech, and medical device companies accelerate commercialization through market research, brand positioning, message testing, patient journey mapping, segmentation, TPP testing, and launch strategy. The firm blends behavioral science expertise with its proprietary AI agent Stella.ai and proprietary methodologies (TechManity, PROsician, WithInsight, Fishbowl, Guided Deliberations, S+R AQuA, IdealSpaces) to deliver insights 25-40% faster than legacy approaches.
Is Shapiro+Raj a public or private company?
Shapiro+Raj is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Shapiro+Raj founded?
Shapiro+Raj was founded in 1961. It employs 51 to 100 people.
Where is Shapiro+Raj based?
Shapiro+Raj is headquartered in Chicago, United States, in the North America region.
How does Shapiro+Raj make money?
Two revenue lines are on record. Strategic Insights Consulting Services are the primary driver. The others are stella.ai Platform Access.
Who are Shapiro+Raj's main competitors?
Broad incumbents on record are IQVIA, Kantar Health (now part of Cerner/envision), DRG (Decision Resources Group) / Clarivate and Evidera (PPD / Thermo Fisher). Direct peers are ZS Associates, Trinity Life Sciences, Prescient Healthcare Group, Syneos Health Consulting and Market Research.com / Lumanity. Genesis Research is listed as an emerging player.
Does Shapiro+Raj have an API?
No public API is recorded for Shapiro+Raj.
What industry is Shapiro+Raj in?
Shapiro+Raj's product category is Pharmaceutical Market Research Consulting. Its primary akta.pro industry code is BPAHALAB, Competitive Intelligence & Benchmarking, with a secondary code of BPAHALAM, Pricing, Revenue & Commercial Analytics. Its NAICS code is 541910 and its SIC code is 8742.